Growth Metrics

Nuwellis (NUWE) Change in Intangibles (2023 - 2026)

Nuwellis posted quarterly Change in Intangibles of $90000.0 for Q1 2026, up 542.86% on a QoQ basis from $14000.0 in Q2 2023.

Nuwellis (NUWE) has 2 years of Change in Intangibles data on file, last reported at $90000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Intangibles changed N/A year-over-year to $90000.0; the trailing twelve-month figure through Mar 2026 stood at $90000.0 (changed N/A YoY), and the FY2023 full-year result was $99000.0, changed N/A from the prior year.
  • Change in Intangibles for Q1 2026 stood at $90000.0, up from $14000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $90000.0 in Q1 2026 and bottomed at $14000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -31.61 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn 90,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 90,000.00
Mar 31, 2026 90,000.00
Jun 30, 2023 14,000.00
Jun 30, 2023 14,000.00
Mar 31, 2023 85,000.00
Mar 31, 2023 85,000.00